House dust mite allergy extract (Allergopharma)

N/A

Report date: 2023/11/01 13:19:35

Base Information

Drug NameHouse dust mite allergy extract (Allergopharma)
Drug Alias Name螨变应原 (Allergopharma)Dermatophagoides pteronyssinus allergoids屋尘螨过敏疫苗 (Allergopharma)Acaroid
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsImmune System DiseasesConjunctivitis, AllergicOtorhinolaryngologic Diseases +[7] 
Global Approved IndicationsImmune System DiseasesOtorhinolaryngologic DiseasesAsthma +[4] 
Approved Indications in ChinaImmune System DiseasesOtorhinolaryngologic DiseasesAsthma +[4] 
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryGermanyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergopharma
China Registration ClassN/A

Develop Information

Active CompaniesAllergopharmaAllergopharma Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsConjunctivitis, AllergicRhinitis, AllergicAsthma
Inactive IndicationsImmune System DiseasesOtorhinolaryngologic DiseasesRespiratory Tract Diseases +[4] 

Other Information

ATC CodeV01AA03
Related LinksN/A